The Food and Drug Administration advisory panel on Thursday unanimously approved BiDiL, a new prescription drug made by Nitromed, which will be marketed for the treatment of heart failure in ...

Staggering statistics reveal a disparity in cardiovascular health in the African-American community. While heart disease is the leading cause of death in America, hospitalization from heart failure is ...

Amgen is teaming up with the Association of Black Cardiologists and Morehouse School of Medicine to run a study examining cardiovascular risk in African Americans. The observational African American ...

The need for pacemakers in Africa will rise as life expectancy and associated cardiovascular diseases increase; however, the pacing field, including appropriate training, facilities and devices, are ...

Heart disease, usually seen as a quintessentially Western problem, is a growing threat in urban Africa, where healthcare systems are ill-equipped to spot danger signals, researchers said on Friday.